Early norepinephrine for sepsis with low blood pressure
Part of Heart & circulation, Infections clinical trials.
This trial tests whether giving a medicine called norepinephrine early and adjusting the dose quickly can help people with sepsis who have very low blood pressure. It is for adults who are diagnosed within the last 3 hours and who have not already received this medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have sepsis (a severe infection affecting your whole body) and your blood pressure is lower than 65 mmHg (the top number)
- This condition was diagnosed within the last 3 hours
- You do not have a do-not-resuscitate (DNR) order
- You are not pregnant
- You do not have other serious conditions (like a stroke, heart attack, or severe bleeding)
- You do not have peripheral artery disease (narrowed leg arteries)
- You have not already received norepinephrine (a blood pressure medicine) for this condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether starting a medicine called norepinephrine early can improve outcomes for adults with sepsis (a serious body-wide response to infection) and low blood pressure. You might be considered if you’re very early in hospital care and meet specific blood pressure and lactate tests.
This trial tests whether giving a second medicine called vasopressin early (along with norepinephrine) helps people with sepsis and low blood pressure better than waiting to use vasopressin only if norepinephrine doesn't work. It may improve blood pressure control and reduce the need for strong medicines.
This trial studies how norepinephrine affects the heart and circulation in adults with septic shock whose blood pressure stays low after the first day. It may help doctors better choose and adjust medicines to support blood pressure and organ function.
This trial tests different combinations of blood pressure medicines given to patients on a breathing machine who have septic shock. The goal is to find the best dose of a second medicine when norepinephrine alone isn't enough.
This study looks at a new way to guide how safely doctors can reduce the strong blood pressure medicine (norepinephrine) in ICU patients with septic shock. Participants must be on a ventilator and have stable blood pressure and heart function.
This trial tests a drug called angiotensin II for people in the emergency room who need a specific dose of norepinephrine (a medicine to raise blood pressure) and are also getting antibiotics. The goal is to see if giving angiotensin II early can help stabilize blood pressure.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.